相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
CD184
- 级别:
CD184 (CXCR4) Antibody
- 目录编号:
CD184 (CXCR4) Antibody
- 克隆性:
单克隆
- 抗原来源:
小鼠
- 保质期:
CD184 (CXCR4) Antibody
- 抗体英文名:
Purified anti-human CD184 (CXCR4) Antibody
- 抗体名:
CD184 (CXCR4) Antibody
- 标记物:
CD184 (CXCR4) Antibody
- 宿主:
小鼠
- 适应物种:
人、猴
- 免疫原:
CD184 (CXCR4) Antibody
- 亚型:
CD184 (CXCR4) Antibody
- 形态:
CD184 (CXCR4) Antibody
- 应用范围:
FC, ICC, CyTOF®, IHC
- 保存条件:
2-8℃
- 浓度:
0.5 mg/mL
- 规格:
25 µg/100 µg
| 规格: | 25 µg | 产品价格: | ¥1400.0 |
|---|---|---|---|
| 规格: | 100 µg | 产品价格: | ¥3200.0 |
Description :CD184, also known as fusin or CXCR4, is a 45 kD seven transmembrane G-protein-linked CXCchemokine receptor. CD184 is widely expressed on blood and tissue cells, including B and Tcells, monocytes, macrophages, dendritic cells, granulocytes, megakaryocytes/platelets,lymphoid, myeloid precursor cells, endothelial cells, epithelial cells, astrocytes, and neurons,among other tissue cells. CD184 is the receptor for CXC chemokine SDF-1, mediates bloodcell migration, and is involved in B lymphopoiesis and myelopoiesis, cardiogenesis, bloodvessel formation, and cerebellar development. CXCR4 is also a coreceptor of X4 HIV-1 and analternative receptor for some isolates of HIV-2.
Verified Reactivity :Human, Cynomolgus, Rhesus
Reported Reactivity :African Green, Baboon, Chimpanzee, Sooty Mangabey
Antibody Type :Monoclonal
Host Species :Mouse
Immunogen :CP-MAC-infected Sup-T1 cells
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation :The antibody was purified by affinity chromatography
Concentration :0.5 mg/mL
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C.
Application :FC - Quality tested、ICC, CyTOF® - Verified、IHC - Reported in the literature, not verified in house
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 10 cells in100 µL volume or 100 µL of whole blood. It is recommended that the reagent be titrated for optimalperformance for each application.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验1. McKnight A, et al. 1997. J. Virol. 71:1692.
2. Endres MJ, et al. 1996. Cell 87:745. (Immunogen, IF)
3. Volin MV, et al. 1998. Biochem. Biophys. Res. Commun. 242:46. (ICC)
4. Berndt C, et al. 1998. P. Natl. Acad. Sci. USA 95:12556. (Block)
5. Ullrich CK, et al. 2000. Blood 96:1438. (Block)
6. Murga M, et al. 2005. Blood 105:1992. (IF)
7. Thompson BD. 2007. J. Biol. Chem. 282:9547. (FC) PubMed
8. Isnardi I, et al. 2010. Blood 115:5026. PubMed
9. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
10. Fischer T, et al. 2008. PLoS One 3:e4069.
11. Schmid BC, et al. 2004. Breast Cancer Res. Treat. 84:247. (IHC)
Product Citations:
1. Mousset CM, et al. 2018. Oncoimmunology. 7:e1488565. PubMed
2. Thompson B, et al. 2007. J Biol Chem. 282:9547. PubMed
3. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
4. Kickler K, et al. 2012. J Immunol. 188:5303. PubMed
5. Eccles JD, et al. 2020. Cell Rep. 30:351. PubMed
6. Del Alcazar D, et al. 2019. Cell Rep. 28:3047. PubMed
7. Kondo N, et al. 2020. Cancers (Basel). 12:00. PubMed
8. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
9. Alhaj Hussen K, et al. 2020. Front Immunol. 11:579776. PubMed
无反应状态或死亡。 在体外联合使用 CD3 和 CD28 的抗体刺激 T 细胞,模拟 T 细胞活化的双信号作用,是进行 T 细胞激活与扩增应用最广泛的方法。除直接使用功能学抗体以外,目前磁珠法(CD3/CD28 抗体偶联磁珠)以及多聚体法(CD3/CD28 抗体偶联 Streptamer 多聚体)也是激活扩增 T 细胞比较常见的两种方法。以上说到的无论是抗体法、磁珠法、亦或者是多聚体法,归根结底都是借助于 CD3 与 CD28 抗体对 T 细胞进行刺激。 下面,我们以小鼠脾脏样本为例,分享
CD4 分子 CD4 常用单克隆抗体或代号:T4,Leu3a 主要表达细胞:Tsub,Msub,Thysub T细胞 分子质量(kDa)和结构:gp55(IgSF) 功 能:与MCHn类分子结合,信号转导,HIV受体 CD4 Aka OKT4, T helper/inducer On chromosome #12p Nonpolymorphous
抗人类免疫缺陷病毒(HIV)感染免疫 艾滋病(AIDS)由人类免疫缺陷病毒(HIV)感染导致,主要感染人体CD4T细胞,导致严重免疫缺陷。据联合国"2005年全球艾滋病传播报告”称:自1981年确认HIV病毒感染以来,迄今累计感染人口6 500万,已造成2 800万人死亡,现有AIDS患者3 800万;2005年死亡患者280万,新感染人口约400万;中国目前实际感染人数超过100万,进入快速增长期。由于AIDS导致的获得性免疫缺陷,患者通常伴有广谱性机会











